Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Rhodium Catalyst. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105732727A reveals a high-yield one-step synthesis method for rhodium catalysts, offering significant cost reduction and supply chain reliability for industrial hydroformylation processes.
Patent CN103087105A discloses novel chiral phosphine ligands enabling high-efficiency asymmetric hydrogenation of beta-aryl enamides with exceptional enantioselectivity.
Novel Rh-catalyzed method for selective benzylic deuteration offers high purity and scalability for API manufacturing, reducing costs and improving supply chain reliability for deuterated drugs.
Patent CN102702270A reveals solvent-free rhodium catalyst synthesis reducing toxic waste and improving yield for industrial chemical manufacturing supply chains.
Patent CN105061126B reveals water-based rhodium catalysis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN102093432A details a high-yield rhodium catalyst synthesis. This report analyzes cost reduction and supply chain reliability for chemical manufacturing.
Novel Rh(I) catalyzed asymmetric B-H insertion for high-purity chiral boranes. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN116947580A enables high-yield axially chiral compound production. Offers supply chain reliability and cost reduction in fine chemical manufacturing for global partners.
Patent CN104892496A details a Rhodium-catalyzed asymmetric hydrogenation method offering high ee values and scalable production for pharmaceutical intermediates.
Patent CN103087105B details high-efficiency asymmetric hydrogenation for chiral beta-aryl amides, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN109988090B reveals a green Rh-catalyzed route for tetrahydropyrroles. Offers high diastereoselectivity and mild conditions for pharma intermediates.
Patent CN109761875B reveals a high-yield Rh-catalyzed method for indole-3-carboxamides, offering cost-effective manufacturing solutions for pharmaceutical intermediates.
Patent CN114044771B reveals a mild Rh-catalyzed tandem reaction for furan-2(5H)-one skeletons, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Rh-catalyzed C-H activation method for high-purity axial chiral intermediates with superior enantioselectivity and scalable process efficiency.
Patent CN115583874B reveals a novel rhodium method for indenone derivatives, offering high enantioselectivity and mild conditions for pharmaceutical supply chains.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN110183443A reveals a novel Rh-catalyzed oxidative coupling for high-purity indolo[3,2-c]quinoline. Achieve cost reduction in pharma intermediate manufacturing with this efficient, halogen-free route.
Novel Rhodium-catalyzed oxidative coupling method enhances purity and reduces waste in API manufacturing, offering a reliable supply chain solution.
Patent CN113735756A details a mild Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and cost-effective manufacturing solutions.
Breakthrough rhodium-catalyzed method enables high-yield synthesis of axichiral dienes with up to 95% ee, offering significant cost reduction in pharmaceutical intermediate manufacturing.